Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Oct
24
2023
Private Space Activity and the Advantages of U.S. Patents for Protecting Space Inventions Foley & Lardner LLP
Nov
6
2023
USPTO Report On COVID-19 Diagnostic Patent Filings Foley & Lardner LLP
Jun
27
2019
The Challenges of Patenting Autonomous Vehicle AI and Software Foley & Lardner LLP
Mar
31
2016
Patent Venue Legislation Could Have A Dramatic Impact on Popular Patent Venues Foley & Lardner LLP
Aug
13
2019
Don’t Feel Bad for Protecting Your Franchise and Trademark Rights Foley & Lardner LLP
Oct
29
2019
USPTO October 2019 Patent Eligibility Guidance Update Includes New Example for Products of Nature Foley & Lardner LLP
Nov
5
2019
Evidence of Copying Must Be Considered In Obviousness Analysis Foley & Lardner LLP
May
19
2016
USPTO 101 Guidance: Microneedles Versus Prosthetic Devices Foley & Lardner LLP
Mar
3
2020
USPTO To Inquire Into 2 Year Delays Foley & Lardner LLP
Mar
31
2020
Utilization of Natural Phenomenon Found Patent Eligible Foley & Lardner LLP
Apr
13
2020
Proposed Legislation To Delay, Then Extend Coronavirus Patents Foley & Lardner LLP
Sep
19
2016
Update: Antitrust-Intellectual Property Licensing Guidelines Foley & Lardner LLP
Oct
27
2016
Virginia District Court Denies Extra Patent Term Adjustment When National Stage Entry Date Falls On A Holiday Foley & Lardner LLP
Dec
6
2016
PTAB Holds Oral Hearings In Tecfidera Patent IPR and Interference Foley & Lardner LLP
May
31
2017
Federal Circuit Questions Applicability of Function Way Result Test In Chemical Cases Foley & Lardner LLP
Mar
22
2021
Will Revised Patent Bar Qualifications Address Low Gender Diversity? Foley & Lardner LLP
Jun
12
2017
Industry Perspectives On The Biosimilar Patent Dance [VIDEO] Foley & Lardner LLP
Jul
18
2017
Coherus Challenges One AbbVie Humira Patent In Four PTAB Proceedings Foley & Lardner LLP
Jun
7
2021
Telemedicine Companies Can Use Patent Law as a Strategic Advantage Foley & Lardner LLP
Apr
3
2015
Hague Agreement Rules Published by USPTO Creating Strategic Considerations for Applicants Foley & Lardner LLP
May
14
2015
First Look At False Marking Under The AIA - America Invents Act Foley & Lardner LLP
Aug
29
2017
CAFC Vacates USPTO Single Reference Obviousness Rejection For Inadequate Showing Of Expectation of Success Foley & Lardner LLP
Mar
15
2022
Understanding the Metaverse Foley & Lardner LLP
Jun
27
2022
Looking Below the Surface for Claim Construction Foley & Lardner LLP
Jul
22
2015
Federal Circuit Finds Biosimilar Patent Dispute Resolution Procedures Optional Foley & Lardner LLP
Jul
28
2015
America Invents Act: Can You File An RCE In That U.S. National Stage Application? Foley & Lardner LLP
Dec
20
2017
Expanded PTAB Panel Finds Sovereign Immunity Waived By Patent Enforcement Foley & Lardner LLP
Jul
30
2015
Sanofi Seeks Inter Partes Review Of Cabilly Patent Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins